
NaNose Medical develops innovative handheld devices for real-time, non-invasive disease detection and monitoring using breath analysis. Their technology leverages nanotechnology and AI to provide accurate diagnostics for over 20 diseases, making healthcare accessible and affordable. The company has received significant support from the EU-EIC for its projects, including ReLiV for liver disease management and LUCIA for lung cancer detection, positioning itself as a leader in early disease diagnosis.

NaNose Medical develops innovative handheld devices for real-time, non-invasive disease detection and monitoring using breath analysis. Their technology leverages nanotechnology and AI to provide accurate diagnostics for over 20 diseases, making healthcare accessible and affordable. The company has received significant support from the EU-EIC for its projects, including ReLiV for liver disease management and LUCIA for lung cancer detection, positioning itself as a leader in early disease diagnosis.